These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10564319)

  • 1. Clinical efficacy and safety of a topical combination of retinaldehyde 0.1% with erythromycin 4% in acne vulgaris.
    Morel P; Vienne MP; Beylot C; Bonérandi JJ; Dréno B; Lehucher-Ceyrac D; Slimani S; Dupuy P
    Clin Exp Dermatol; 1999 Sep; 24(5):354-7. PubMed ID: 10564319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical assessment of topical erythromycin gel with and without zinc acetate for treating mild-to-moderate acne vulgaris.
    Sayyafan MS; Ramzi M; Salmanpour R
    J Dermatolog Treat; 2020 Nov; 31(7):730-733. PubMed ID: 30998422
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and tolerability of combined topical treatment of acne vulgaris with tretinoin and erythromycin in general practice.
    Korting HC; Braun-Falco O
    Drugs Exp Clin Res; 1989; 15(9):447-51. PubMed ID: 2534292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
    Kellett N; West F; Finlay AY
    Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of 0.1% retinaldehyde/ 6% glycolic acid (diacneal) for mild to moderate acne vulgaris. A multicentre, double-blind, randomized, vehicle-controlled trial.
    Poli F; Ribet V; Lauze C; Adhoute H; Morinet P
    Dermatology; 2005; 210 Suppl 1():14-21. PubMed ID: 15724103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris.
    Pazoki-Toroudi H; Nassiri-Kashani M; Tabatabaie H; Ajami M; Habibey R; Shizarpour M; Babakoohi S; Rahshenas M; Firooz A
    J Dermatolog Treat; 2010 May; 21(3):212-6. PubMed ID: 20394495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 4% erythromycin and zinc combination (Zineryt) versus 2% erythromycin (Eryderm) in acne vulgaris: a randomized, double-blind comparative study.
    Habbema L; Koopmans B; Menke HE; Doornweerd S; De Boulle K
    Br J Dermatol; 1989 Oct; 121(4):497-502. PubMed ID: 2533878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris.
    Zouboulis CC; Derumeaux L; Decroix J; Maciejewska-Udziela B; Cambazard F; Stuhlert A
    Br J Dermatol; 2000 Sep; 143(3):498-505. PubMed ID: 10971320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative efficacy of benzoyl peroxide 5%/erythromycin 3% gel and erythromycin 4%/zinc 1.2% solution in the treatment of acne vulgaris.
    Chu A; Huber FJ; Plott RT
    Br J Dermatol; 1997 Feb; 136(2):235-8. PubMed ID: 9068739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
    McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of a topical erythromycin/tretinoin combination preparation in acne treatment: post-marketing surveillance study involving over 6500 patients.
    Kreusch J; Bextermöller R
    Curr Med Res Opin; 2000; 16(1):1-7. PubMed ID: 16422028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The association tretinoin-erythromycin base: a new topical treatment for acne. Results of a multicentric trial on 347 cases (authors transl)].
    Amblard P; Bazex A; Beylot C; Civatte J; Garrel J; Grupper C; Hincky M; Meynadier J; Privat Y; Thivolet J
    Sem Hop; 1980 May 8-15; 56(17-18):911-5. PubMed ID: 6248979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical nadifloxacin 1% cream vs. topical erythromycin 4% gel in the treatment of mild to moderate acne.
    Tunca M; Akar A; Ozmen I; Erbil H
    Int J Dermatol; 2010 Dec; 49(12):1440-4. PubMed ID: 21091683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical erythromycin solution in acne. Results of a multiclinic trial.
    Dobson RL; Belknap BS
    J Am Acad Dermatol; 1980 Nov; 3(5):478-82. PubMed ID: 6452463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0.05%) and erythromycin (2%) with gels containing isotretinoin (0.05%) or erythromycin (2%) alone in the topical treatment of acne vulgaris.
    Glass D; Boorman GC; Stables GI; Cunliffe WJ; Goode K
    Dermatology; 1999; 199(3):242-7. PubMed ID: 10592405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acne vulgaris: combination of 3% erythromycin and 5% benzoyl peroxide in a gel compared to clindamycin phosphate lotion.
    Packman AM; Brown RH; Dunlap FE; Kraus SJ; Webster GF
    Int J Dermatol; 1996 Mar; 35(3):209-11. PubMed ID: 8655242
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of topical erythromycin 1.5 percent solution versus topical clindamycin phosphate 1.0 percent solution in the treatment of acne vulgaris.
    Thomas DR; Raimer S; Smith EB
    Cutis; 1982 Jun; 29(6):624-5, 628-32. PubMed ID: 6213379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation.
    Schachner L; Pestana A; Kittles C
    J Am Acad Dermatol; 1990 Mar; 22(3):489-95. PubMed ID: 2138180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new salt of erythromycin (A-137 or erythromycin lauryl sulfate) in the topical treatment of acne].
    Pérez López M; Moragas Viñas JM
    Med Cutan Ibero Lat Am; 1982; 10(3):151-8. PubMed ID: 6218350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.